American Century Companies Inc. lessened its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 4.1% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 4,602,808 shares of the company's stock after selling 195,462 shares during the quarter. American Century Companies Inc. owned about 3.78% of Henry Schein worth $315,246,000 at the end of the most recent reporting period.
A number of other hedge funds have also added to or reduced their stakes in HSIC. Guggenheim Capital LLC lifted its holdings in Henry Schein by 2.5% in the 4th quarter. Guggenheim Capital LLC now owns 6,428 shares of the company's stock worth $445,000 after buying an additional 159 shares during the period. UMB Bank n.a. lifted its holdings in Henry Schein by 23.2% in the 1st quarter. UMB Bank n.a. now owns 1,066 shares of the company's stock worth $73,000 after buying an additional 201 shares during the period. Humankind Investments LLC lifted its holdings in Henry Schein by 7.4% in the 4th quarter. Humankind Investments LLC now owns 3,057 shares of the company's stock worth $212,000 after buying an additional 211 shares during the period. HB Wealth Management LLC lifted its holdings in Henry Schein by 1.5% in the 1st quarter. HB Wealth Management LLC now owns 15,419 shares of the company's stock worth $1,056,000 after buying an additional 226 shares during the period. Finally, J. Safra Sarasin Holding AG lifted its holdings in Henry Schein by 1.1% in the 4th quarter. J. Safra Sarasin Holding AG now owns 22,098 shares of the company's stock worth $1,529,000 after buying an additional 231 shares during the period. Hedge funds and other institutional investors own 96.62% of the company's stock.
Analyst Upgrades and Downgrades
Several equities research analysts have weighed in on HSIC shares. Wells Fargo & Company dropped their price objective on Henry Schein from $80.00 to $75.00 and set an "equal weight" rating for the company in a report on Tuesday, May 6th. UBS Group lowered their target price on Henry Schein from $75.00 to $70.00 and set a "neutral" rating for the company in a research note on Wednesday, August 6th. Stifel Nicolaus restated a "hold" rating and issued a $75.00 target price (down previously from $80.00) on shares of Henry Schein in a research note on Friday, July 25th. Piper Sandler lowered their target price on Henry Schein from $83.00 to $77.00 and set an "overweight" rating for the company in a research note on Wednesday, April 30th. Finally, Baird R W cut Henry Schein from a "strong-buy" rating to a "hold" rating in a research note on Monday, July 14th. Nine analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat, the company has an average rating of "Hold" and an average target price of $75.58.
Read Our Latest Report on HSIC
Henry Schein Stock Down 0.1%
Shares of Henry Schein stock traded down $0.07 on Friday, reaching $67.84. The company's stock had a trading volume of 1,675,382 shares, compared to its average volume of 2,100,586. The company has a market capitalization of $8.23 billion, a price-to-earnings ratio of 21.88, a P/E/G ratio of 2.24 and a beta of 0.81. The firm's fifty day simple moving average is $70.81 and its two-hundred day simple moving average is $70.72. Henry Schein, Inc. has a 52 week low of $60.56 and a 52 week high of $82.49. The company has a quick ratio of 0.78, a current ratio of 1.41 and a debt-to-equity ratio of 0.51.
Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its earnings results on Tuesday, August 5th. The company reported $1.10 EPS for the quarter, missing analysts' consensus estimates of $1.19 by ($0.09). The business had revenue of $3.24 billion during the quarter, compared to the consensus estimate of $3.22 billion. Henry Schein had a return on equity of 14.36% and a net margin of 3.05%. The firm's revenue for the quarter was up 3.3% on a year-over-year basis. During the same period in the previous year, the business posted $1.23 EPS. Equities analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current year.
About Henry Schein
(
Free Report)
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Featured Articles

Before you consider Henry Schein, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Henry Schein wasn't on the list.
While Henry Schein currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.